Covered recipient · General Payments record
KRISTEN EILEEN COPELAND
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2021–2024
$6,709.50
- Reported across 246 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,765.39 | 70 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $206.88 | 14 |
| Astellas Pharma US Inc | $158.24 | 3 |
| Genentech, Inc. | $132.14 | 1 |
| Amgen Inc. | $131.87 | 1 |
| Genentech USA, Inc. | $125.20 | 6 |
| Acerta Pharma LLC | $109.24 | 5 |
| ABBVIE INC. | $96.07 | 4 |
| Daiichi Sankyo Inc. | $68.67 | 3 |
| E.R. Squibb & Sons, L.L.C. | $64.09 | 3 |
| Bayer HealthCare Pharmaceuticals Inc. | $56.36 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $54.97 | 2 |
| Janssen Biotech, Inc. | $49.99 | 2 |
| Gilead Sciences, Inc. | $49.29 | 2 |
| Alexion Pharmaceuticals, Inc. | $48.58 | 2 |
| Celgene Corporation | $45.65 | 2 |
| BeiGene USA, Inc. | $39.23 | 2 |
| ARRAY BIOPHARMA INC | $29.65 | 3 |
| TerSera Therapeutics LLC | $29.07 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $27.19 | 1 |
| AVEO Pharmaceuticals, Inc. | $26.24 | 1 |
| Exelixis Inc. | $24.88 | 1 |
| PharmaEssentia USA Corporation | $24.85 | 1 |
| Mirati Therapeutics, Inc. | $23.04 | 1 |
| Lilly USA, LLC | $22.51 | 1 |
| ADC Therapeutics America, Inc. | $22.17 | 1 |
| Coherus Biosciences Inc. | $21.93 | 1 |
| Incyte Corporation | $20.31 | 1 |
| SOBI, INC | $20.26 | 1 |
| Myriad Genetic Laboratories, Inc. | $19.28 | 1 |
| Ipsen Biopharmaceuticals, Inc | $17.54 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (70)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.